IMCD opens Mexico HQ
IMCD has opened its new Mexican headquarters. This covers an area of 810 m2 in a LEED Gold-certified building in the Torre Polanco development in Mexico City. It will be a centralised hub for the company’s digitalisation initiatives, formulation capabilities and business operations.
“Our modern workplace was designed to foster growth and cultivate partnerships as we aim to create a world of opportunity for our emerging market in Mexico,” said Miguel Ruiseñor, managing director of IMCD México, which employs 106 and comprises the former DCS Pharma, acquired in 2019, and additional acquisitions of Millikan, Banner Química and Maquimex.
RELATED ARTICLES
The US Environmental Protection Agency (EPA) has taken two separate actions on per- and polyfluorinated substances (PFAS), both being part of its PFAS strategic roadmap, which aims to implement legislation by Q4 to reduce and destroy PFAS contamination in water, air and soil.
The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on hum
Lubrizol has opened a new Global Capability Centre (GCC) in Pune, India, as “a strategic hub to accelerate its growth in the region and enable closer collaboration for its customers and employees”.
International Process Plants (IPP), which buys and sells industrial plants and equipment, has acquired Henkel’s detergent plant in Lomazzo, Italy, in partnership with Maynards, a specialist in industrial liquidation auction services.
Chemours has completed its planned procedures with respect to an internal review that it first announced on 29 February. This essentially confirmed the details revealed in an interim report on 7 March.
Symrise and India’s Virchow Group have agreed to make personal care ingredients from the Symrise portfolio through a new joint venture called Vizag Care Ingredients, beginning within 1H. This will be based on Virchow’s synthetic chemistry capabilities for API manufacture.
